The effect of a third-dose BNT162b2 vaccine on anti-SARS-CoV-2 antibody levels in immunosuppressed patients

OBJECTIVES: The recent surge in coronavirus disease 2019 cases led to the consideration of a booster vaccine in previously vaccinated immunosuppressed individuals. However, the immunogenic effect of a third-dose severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine in immunosuppressed...

Descripción completa

Detalles Bibliográficos
Autores principales: Saiag, Esther, Grupper, Ayelet, Avivi, Irit, Elkayam, Ori, Ram, Ron, Herishanu, Yair, Cohen, Yael, Perry, Chava, Furer, Victoria, Katchman, Helena, Rabinowich, Liane, Ben-Yehoyada, Merav, Halperin, Tami, Baruch, Roni, Goldshmidt, Hanoch, Hagin, David, Ben-Ami, Ronen, Sprecher, Eli, Bomze, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:
Research Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853982/
https://www.ncbi.nlm.nih.gov/pubmed/35183747
http://dx.doi.org/10.1016/j.cmi.2022.02.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853982/
https://www.ncbi.nlm.nih.gov/pubmed/35183747
http://dx.doi.org/10.1016/j.cmi.2022.02.002

Ejemplares similares